Authors:
Lincoff, AM
Kereiakes, DJ
Mascelli, MA
Deckelbaum, LI
Barnathan, ES
Patel, KK
Frederick, B
Nakada, MT
Topol, EJ
Citation: Am. Lincoff et al., Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization, CIRCULATION, 104(2), 2001, pp. 163-167
Authors:
Molino, M
Woolkalis, MJ
Prevost, N
Pratico, D
Barnathan, ES
Taraboletti, G
Haggarty, BS
Hesselgesser, J
Horuk, R
Hoxie, JA
Brass, LF
Citation: M. Molino et al., CXCR4 on human endothelial cells can serve as both a mediator of biological responses and as a receptor for HIV-2, BBA-MOL BAS, 1500(2), 2000, pp. 227-240
Authors:
Coulter, SA
Cannon, CP
Ault, KA
Antman, EM
Van de Werf, F
Adgey, AJJ
Gibson, CM
Giugliano, RP
Mascelli, MA
Scherer, J
Barnathan, ES
Braunwald, E
Kleiman, NS
Citation: Sa. Coulter et al., High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction - Results from TIMI (thrombolysis in myocardial infarction) 14, CIRCULATION, 101(23), 2000, pp. 2690-2695
Citation: K. Kariko et al., Overexpression of urokinase receptor in mammalian cells following administration of the in vitro transcribed encoding mRNA, GENE THER, 6(6), 1999, pp. 1092-1100
Citation: Aw. Chang et al., Urokinase receptor-dependent upregulation of smooth muscle cell adhesion to vitronectin by urokinase, ART THROM V, 18(12), 1998, pp. 1855-1860